Stay updated with breaking news from Sanderson Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company plans to analyze both traditional and real-world data from about 8,000 individuals to validate and optimize its multi-cancer early detection platform.
The precision medicine initiative will use real-world data from the Learning Health Network for clinical validation and refinement of cancer risk prediction models.
Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network
With real-world data from its Learning Health Network, Cerner hopes to advance oncology innovation and expand access to clinical trials.
The company's Learning Health Network teams with Elligo Health Research and Freenome to Advance Early Cancer Detection KANSAS CITY, Mo., May 18, 2...